MGX   $1.375  -1.08% Market Open

Metagenomi Therapeutics, Inc.
Total Cash 299.92M
totalCashPerShare 8.013
EBITDA -83.55M
Total Debt 47.94M
quickRatio 5.737
currentRatio 5.824
Total Revenue 55.93M
debtToEquity 17.794
Revenue/Share 3.758
ROA -0.13921
ROE -0.28978002
grossProfits
freeCashflow -57.57M
operatingCashflow -100.48M
earningsGrowth
revenueGrowth 0.765
grossMargins -0.99093
ebitdaMargins -1.49384
operatingMargins -0.84281
profitMargins -1.3410001
enterpriseValue -173.00M
forwardPE -0.72758615
floatShares 23.39M
sharesOutstanding 37.43M
sharesShort 369.49K
sharesShortPriorMonth 199.81K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.29%
heldPercentInstitutions 0.36%
Short Ratio help_outline 1.04%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 7.192
Price To Book help_outline 0.29
earningsQuarterlyGrowth
netIncomeToCommon -75.00M
trailingEps -2.00%
forwardEps -2.90%
enterpriseToEbitda 2.07
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.78 3Q 2024
institutionsCount 74
lastUpdated Nov. 2, 2024, 7:08 a.m.